Reven Pharmaceuticals, Inc.
SARASOTA, FL · CIK 0001556231 · Biotech · Private
Pharmacological therapeutics developed through drug discovery and development
reven.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $23K
- 3 Form D · Feb 2014
- 152 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 7 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201220132014
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $22,500 | |
| Private capital raised | Form D · SEC | $7,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1826 | Magna Pharmaceuticals, Inc. | — | $1.0M |
| 1827 | CanaQuest Medical Corp. | — | $31K |
| 1828 | NMN Holdings LP | — | — |
| 1829 | Reven Pharmaceuticals, Inc. | — | $23K |
| 1830 | Harton, Inc. | — | $15M |
| 1831 | SciTech Development, Inc. | — | $470K |
| 1832 | Habelo Beauty, LLC | — | $25K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brian DenommeDirector · Executive Officer
- Michael HandleyExecutive Officer
- Peter LangeDirector · Executive Officer
- Michael VolkExecutive Officer
Patents
- Pharmaceutical Compositions And Methods For Prevention And/or Treatment Of Inflammationapplication
- Pharmaceutical Compositions And Methods For Prevention And/or Treatment Of Inflammationapplication
- Method Of Treating Or Ameliorating Skin Conditions With A Magnetic Dipole Stabilized Solutionapplication
- Method Of Treating Or Ameliorating Skin Conditions With A Magnetic Dipole Stabilized Solutiongranted
- Compositions And Methods For The Prevention And Treatment Of Cardiovascular Diseasesapplication
- Compositions And Methods For The Prevention And Treatment Of Cardiovascular Diseasesgranted
- Methods Of Treating Or Ameliorating Skin Conditions With A Magnetic Dipole Stabilized Solutiongranted
- Compositions And Methods For The Prevention And Treatment Of Cardiovascular Diseasesgranted
- Methods Of Treating Or Ameliorating Skin Conditions With A Magnetic Dipole Stabilized Solutiongranted
- Compositions And Methods For The Prevention And Treatment Of Cardiovascular Diseasesgranted
- Compositions And Methods For The Prevention And Treatment Of Cardiovascular Diseasesgranted
- Compositions And Methods For The Treatment Of Metabolic Conditionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.